Maulik Nanavaty is senior vice president and president of the neuromodulation division for Boston Scientific and a member of its executive committee. In this role, he is responsible for the innovation leader in less-invasive microelectronic implantable technologies used to treat chronic neuropathic pain. Prior to his current role, Nanavaty was president of Boston Scientific Japan. Previously, he was vice president and general manager of the company’s interventional cardiology business in Japan. During his tenure, Nanavaty managed the successful launch of the company’s TAXUS Express2 drug-eluting stent system in that country. He joined Boston Scientific in 2005 as vice president of corporate strategy for Japan, where he transformed the business and increased operational efficiency. Prior to joining Boston Scientific, Nanavaty spent 16 years working in various executive positions at Baxter International Inc. and Baxter Japan. Nanavaty earned his doctorate in pharmaceutical sciences from the University of Illinois and his master’s in business administration from the University of Chicago.